[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.149.128. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
December 17, 2003

Acarbose for Patients With Hypertension and Impaired Glucose ToleranceAcarbose for Patients With Hypertension and Impaired Glucose Tolerance

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;290(23):3066. doi:10.1001/jama.290.23.3066-a

To the Editor: Dr Chiasson and colleagues1 speculated that by decreasing postprandial glucose levels, acarbose could decrease oxidative stress and thus ameliorate the endothelial dysfunction associated with the postprandial state. The authors speculated that this could account for the beneficial cardiovascular effect of acarbose in patients with IGT.

First Page Preview View Large
First page PDF preview
First page PDF preview
×